184 related articles for article (PubMed ID: 18180374)
1. Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue.
Brighton PJ; Wise A; Dass NB; Willars GB
J Pharmacol Exp Ther; 2008 Apr; 325(1):154-64. PubMed ID: 18180374
[TBL] [Abstract][Full Text] [Related]
2. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
Brighton PJ; Szekeres PG; Wise A; Willars GB
Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin U and its receptors: structure, function, and physiological roles.
Brighton PJ; Szekeres PG; Willars GB
Pharmacol Rev; 2004 Jun; 56(2):231-48. PubMed ID: 15169928
[TBL] [Abstract][Full Text] [Related]
4. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells.
Shukla AK; Haase W; Reinhart C; Michel H
Int J Biochem Cell Biol; 2007; 39(5):931-42. PubMed ID: 17445746
[TBL] [Abstract][Full Text] [Related]
5. Neuromedin U: physiology, pharmacology and therapeutic potential.
Budhiraja S; Chugh A
Fundam Clin Pharmacol; 2009 Apr; 23(2):149-57. PubMed ID: 19645813
[TBL] [Abstract][Full Text] [Related]
6. Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro.
Jones NA; Morton MF; Prendergast CE; Powell GL; Shankley NP; Hollingsworth SJ
Regul Pept; 2006 Sep; 136(1-3):109-16. PubMed ID: 16782214
[TBL] [Abstract][Full Text] [Related]
7. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.
Prendergast CE; Morton MF; Figueroa KW; Wu X; Shankley NP
Br J Pharmacol; 2006 Apr; 147(8):886-96. PubMed ID: 16474416
[TBL] [Abstract][Full Text] [Related]
8. Identification of receptors for neuromedin U and its role in feeding.
Howard AD; Wang R; Pong SS; Mellin TN; Strack A; Guan XM; Zeng Z; Williams DL; Feighner SD; Nunes CN; Murphy B; Stair JN; Yu H; Jiang Q; Clements MK; Tan CP; McKee KK; Hreniuk DL; McDonald TP; Lynch KR; Evans JF; Austin CP; Caskey CT; Van der Ploeg LH; Liu Q
Nature; 2000 Jul; 406(6791):70-4. PubMed ID: 10894543
[TBL] [Abstract][Full Text] [Related]
9. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.
Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M
J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuromedin U effects in canine smooth muscle.
Westfall TD; McCafferty GP; Pullen M; Gruver S; Sulpizio AC; Aiyar VN; Disa J; Contino LC; Mannan IJ; Hieble JP
J Pharmacol Exp Ther; 2002 Jun; 301(3):987-92. PubMed ID: 12023529
[TBL] [Abstract][Full Text] [Related]
11. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
12. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).
Kojima M; Haruno R; Nakazato M; Date Y; Murakami N; Hanada R; Matsuo H; Kangawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):435-8. PubMed ID: 11027493
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor A mediates VIP inhibition of contraction.
Cheng L; Biancani P; Behar J
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G433-9. PubMed ID: 20019164
[TBL] [Abstract][Full Text] [Related]
14. Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.
Dass NB; Bassil AK; North-Laidler VJ; Morrow R; Aziz E; Tuladhar BR; Sanger GJ
Br J Pharmacol; 2007 Feb; 150(4):502-8. PubMed ID: 17211455
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation.
Mitchell JD; Kuc RE; Maguire JJ; Davenport AP
Vet J; 2010 Oct; 186(1):106-9. PubMed ID: 19683464
[TBL] [Abstract][Full Text] [Related]
16. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.
Rucinski M; Ziolkowska A; Tyczewska M; Szyszka M; Malendowicz LK
Int J Mol Med; 2008 Sep; 22(3):363-8. PubMed ID: 18698496
[TBL] [Abstract][Full Text] [Related]
17. Emodin augments calcium activated chloride channel in colonic smooth muscle cells by Gi/Go protein.
Xu L; Ting-Lou ; Lv N; Zhu X; Chen Y; Yang J
Eur J Pharmacol; 2009 Aug; 615(1-3):171-6. PubMed ID: 19409890
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the rat uterine neuromedin U receptor.
Nandha KA; Benito-Orfila MA; Smith DM; Bloom SR
Endocrinology; 1993 Aug; 133(2):482-6. PubMed ID: 8393763
[TBL] [Abstract][Full Text] [Related]
19. Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.
Aiyar N; Disa J; Foley JJ; Buckley PT; Wixted WE; Pullen M; Shabon U; Dul E; Szekeres PG; Elshourbagy NA; Sarau HM; Appelbaum E; Bolaky J
Pharmacology; 2004 Sep; 72(1):33-41. PubMed ID: 15292653
[TBL] [Abstract][Full Text] [Related]
20. Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus.
Qiu DL; Chu CP; Tsukino H; Shirasaka T; Nakao H; Kato K; Kunitake T; Katoh T; Kannan H
Neurosci Lett; 2005 Feb; 374(1):69-72. PubMed ID: 15631899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
